Samorita Hospital Limited

DSE:SAMORITA Stock Report

Market Cap: ৳1.5b

Samorita Hospital Past Earnings Performance

Past criteria checks 2/6

Samorita Hospital's earnings have been declining at an average annual rate of -20.2%, while the Healthcare industry saw earnings growing at 15.2% annually. Revenues have been declining at an average rate of 1.9% per year. Samorita Hospital's return on equity is 1.2%, and it has net margins of 3.7%.

Key information

-20.2%

Earnings growth rate

-20.2%

EPS growth rate

Healthcare Industry Growth13.4%
Revenue growth rate-1.9%
Return on equity1.2%
Net Margin3.7%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Samorita Hospital makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DSE:SAMORITA Revenue, expenses and earnings (BDT Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23371141690
30 Sep 23371161650
30 Jun 2333411580
31 Mar 2331711500
31 Dec 22308-11580
30 Sep 22301-11430
30 Jun 22338161440
31 Mar 22368361460
31 Dec 21380401480
30 Sep 21421561830
30 Jun 21394421510
31 Mar 21331111720
31 Dec 2033691730
30 Sep 20305-71440
30 Jun 2032131740
31 Mar 20381301550
31 Dec 19379341540
30 Sep 19386401520
30 Jun 19374321500
31 Mar 19373261510
31 Dec 18378261500
30 Sep 18378241490
30 Jun 18370241470
31 Mar 18381331430
31 Dec 17380361410
30 Sep 17385431390
30 Jun 17377381370
31 Mar 17371361380
31 Dec 16372331380
30 Sep 16363281360
30 Jun 16370341340
31 Mar 16363401280
31 Dec 15353401260
30 Sep 15345391260
30 Jun 15343381250
31 Mar 15345421250
31 Dec 14347431240
30 Sep 14339421200
30 Jun 14332411200
31 Mar 14327341130
31 Dec 13323361100
30 Sep 13324351090
30 Jun 13322341060

Quality Earnings: SAMORITA has high quality earnings.

Growing Profit Margin: SAMORITA became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: SAMORITA's earnings have declined by 20.2% per year over the past 5 years.

Accelerating Growth: SAMORITA has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: SAMORITA has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (3.2%).


Return on Equity

High ROE: SAMORITA's Return on Equity (1.2%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.